No, haven't traded Epitan / Clinuvel since 2006! It's been on my watchlist though and I have seen it turn into a ten-bagger from $4.50 to $45 over the last few years. I believe the next major phase could be a take-over once their lead drug becomes market ready. Keep an eye out for news on collaboration with a large pharma (I'M NOT SAYING THIS WILL HAPPEN). CUV really is the little engine that could...
Price targets, page-42
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.60 |
Change
-0.200(1.35%) |
Mkt cap ! $731.5M | |||
| Open | High | Low | Value | Volume |
| $14.64 | $14.85 | $14.58 | $346.2K | 23.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 89 | $14.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.65 | 80 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$14.58 |
Change
-0.200 ( 2.07 %) |
||||
| Open | High | Low | Volume | ||
| $14.66 | $14.86 | $14.58 | 2914 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| CUV (ASX) Chart |
